|
Author | No. of patients | Margin | Dissected lymph nodes | Length of specimen | Mortality | Morbidity | Readmission | Hospital stay |
Postoperative pain score |
(groups) | (% positive) | | (cm) | (%) | (%) | (%) | (days) |
|
McNally et al. [19] | 27 versus 46 (SILC versus LAC) | 0 versus 0 | 15# versus 17#
| NA | 0 versus 4.3 (β=βNA) | 18.5 versus 34.8 (=βNA) | NA | 3# versus 5#
| NA |
|
Ramos-Valadez et al. [22] | 20 versus 20 (SILC versus LAC) | 0 versus 0 | 20.3 versus 18.3 | NA | 0 versus 0 | 10.0 versus 10.0 | 0 versus 0 | 3.2 versus 3.8 | NA |
|
Wolthuis et al. [24] | 14 versus 14 (SILC versus LAC) | 0 versus 0 | 12# versus 14# () | 17# versus 18#
| 0 versus 0 | 0 versus 0 | 0 versus 0 | 7# versus 6#
| Overall mean1.00 versus 1.39
|
|
Champagne et al. [27] | 29 versus 29 (SILC versus LAC) | 0 versus 0 | 19.4 versus 21.6
| 44 versus 44
| NA | 17.2 versus 24.1
| NA | 3.7 versus 3.9
| NA |
|
Chen et al. [30] | 18 versus 21 (SILC versus LAC) | Distal free margin (cm) 16 versus 13.5
| 19.5# versus 19#
| NA | 0 versus 0 | 16.6 versus 9.5
| 0 versus 0 | 5# versus 5#
| Demerol usage (mg) 10# versus 10#
|
|
Papaconstantinou et al. [31] | 29 versus 29 versus 29 (SILC versus LAC versus HALS) | NA | 16.4 versus 16.9 versus 18.1
| NA | 0 versus 0 versus 0 | (i) Leakage 3.4 versus 0 versus 0
(ii) SSI 6.9 versus 10.3 versus 6.9
(iii) Minor wound complication 10.3 versus 13.8 versus 17.2
| 13.8 versus 6.9 versus 10.3
| 3.4 versus 4.6 versus 4.9 ( P< 0.05) | Mean maximum Day 1: 4.7 versus 6.0 versus 6.0 ( P< 0.05) Day 2: 3.8 versus 5.2 versus 5.0 ( P< 0.05) |
|
Gandhi et al. [33] | 24 versus 24 (SILC versus HALS) | NA | 24.6 versus 18.6
| NA | NA | 8.3 versus 0
| NA | 2.7 versus 3.3 ( P= 0.02) | NA |
|
Waters et al. [35] | 16 versus 27 (SILC versus LAC) | 0 versus 0 | 18 versus 16
| 18 versus 18
| 0 versus 3.7
| 18.8 versus 14.8
| 6.3 versus 3.7
| 5 versus 6
| NA |
|
Adair et al. [36] | 17 versus 17 (SILC versus LAC) | NA | 20.1 versus 18.6
| NA | 5.9 versus 0
| 29.4 versus 23.5
| NA | 3.9 versus 4.1
| NA |
|